JPS5748160B2 - - Google Patents

Info

Publication number
JPS5748160B2
JPS5748160B2 JP54164025A JP16402579A JPS5748160B2 JP S5748160 B2 JPS5748160 B2 JP S5748160B2 JP 54164025 A JP54164025 A JP 54164025A JP 16402579 A JP16402579 A JP 16402579A JP S5748160 B2 JPS5748160 B2 JP S5748160B2
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP54164025A
Other languages
Japanese (ja)
Other versions
JPS5687599A (en
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to JP16402579A priority Critical patent/JPS5687599A/ja
Priority to US06/215,928 priority patent/US4386076A/en
Priority to DE8080107949T priority patent/DE3064165D1/de
Priority to EP80107949A priority patent/EP0031128B1/en
Priority to CA000367108A priority patent/CA1150247A/en
Priority to ES498020A priority patent/ES498020A0/es
Publication of JPS5687599A publication Critical patent/JPS5687599A/ja
Publication of JPS5748160B2 publication Critical patent/JPS5748160B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP16402579A 1979-12-19 1979-12-19 E 55 22halogenovinyl arabinofuranosyluracil and its preparation Granted JPS5687599A (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
JP16402579A JPS5687599A (en) 1979-12-19 1979-12-19 E 55 22halogenovinyl arabinofuranosyluracil and its preparation
US06/215,928 US4386076A (en) 1979-12-19 1980-12-12 (E)-5-(2-Halogenovinyl)-arabinofuranosyluracil, process for preparation thereof, and uses thereof
DE8080107949T DE3064165D1 (en) 1979-12-19 1980-12-16 (e)-5-(2-halogenovinyl)-arabinofuranosyluracil, process for preparation thereof, and uses thereof
EP80107949A EP0031128B1 (en) 1979-12-19 1980-12-16 (e)-5-(2-halogenovinyl)-arabinofuranosyluracil, process for preparation thereof, and uses thereof
CA000367108A CA1150247A (en) 1979-12-19 1980-12-18 (e)-5-(2-halogenovinyl)-arabinofuranosyluracil, process for preparation thereof, and uses thereof
ES498020A ES498020A0 (es) 1979-12-19 1980-12-19 Un procedimiento para al preparacion de un ce)-5-(halogenovinil)-arabino-furano-siluracilo.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP16402579A JPS5687599A (en) 1979-12-19 1979-12-19 E 55 22halogenovinyl arabinofuranosyluracil and its preparation

Publications (2)

Publication Number Publication Date
JPS5687599A JPS5687599A (en) 1981-07-16
JPS5748160B2 true JPS5748160B2 (enExample) 1982-10-14

Family

ID=15785357

Family Applications (1)

Application Number Title Priority Date Filing Date
JP16402579A Granted JPS5687599A (en) 1979-12-19 1979-12-19 E 55 22halogenovinyl arabinofuranosyluracil and its preparation

Country Status (6)

Country Link
US (1) US4386076A (enExample)
EP (1) EP0031128B1 (enExample)
JP (1) JPS5687599A (enExample)
CA (1) CA1150247A (enExample)
DE (1) DE3064165D1 (enExample)
ES (1) ES498020A0 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU183567B (en) * 1981-09-07 1984-05-28 Mta Koezponti Kemiai Kutato In Process for preparing /e/-5-/2-bromo-vinyl/-uridine and derivatives thereof
JPS5843993A (ja) * 1981-09-09 1983-03-14 Yamasa Shoyu Co Ltd １−β−Ｄ−アラビノフラノシル−（Ｅ）−５−（２−ハロゲノビニル）ウラシル−５′−りん酸およびその製造法
US4782142A (en) * 1982-01-05 1988-11-01 The Research Foundation Of State University Of New York Novel 5-substituted 2-pyrimidinone nucleosides and methods of use
JPS58225097A (ja) * 1982-06-23 1983-12-27 Yamasa Shoyu Co Ltd ヌクレオシド５′−アルキルもしくはアルケニルりん酸
HU192472B (en) * 1984-10-12 1987-06-29 Mta Koezponti Kemiai Kutato In Process for preparing /e/-5-/2-bromo-vinyl/-uracyl derivatives
SE8605503D0 (sv) * 1986-12-19 1986-12-19 Astra Laekemedel Ab Novel medicinal use
US5215971A (en) * 1986-12-19 1993-06-01 Medivir Ab Antiviral pharmaceutical composition comprising 5-substituted pyrimidine nucleosides
WO1990001324A1 (en) * 1988-08-10 1990-02-22 Stephen Leslie Sacks PRODUCTION OF RADIOIODINATED 1-β-D-ARABINOFURANOSYL)-5(E)-(2-IODOVINYL)URACIL, AND USES THEREOF, AND RELATED ANALOGUES INCORPORATING ALTERNATIVE HALOGEN RADIONUCLIDES, THE GENERAL RADIOHALOGENATION PRECURSORS, 1-(2,3,5-TRI-O-ACETYL-β-D-ARABINOFURANOSYL)-5(Z and E)-(2-TRIMETHYLSILYLVINYL)URACIL, PROCESSES FOR RADIOHA
GB8912972D0 (en) * 1989-06-06 1989-07-26 Wellcome Found Therapeutic nucleosides
US5352584A (en) * 1990-01-22 1994-10-04 E. R. Squibb & Sons, Inc. Monoclonal antibodies which bind (E)-5- (2-bromovinyl)-arabinofuranosyluracil and diagnostic methods based thereon
CA2085994A1 (en) * 1991-04-24 1992-10-25 Shinji Sakata 1-beta-d-arabinofuranosyl-(e)-5- (2-halogenovinyl) uracil derivatives
US5446031A (en) * 1991-04-24 1995-08-29 Yamasa Shuyu Kabushiki Kaisha 1-β-D-arabinofuranosyl-(E)-5-(2-halogenovinyl)uracil derivatives
US5248771A (en) * 1991-06-26 1993-09-28 Triumf Process for preparing no-carrier-added radiohalogenated vinyl nucleosides
FI20012151A0 (fi) * 2001-11-05 2001-11-05 Danisco Nestemäinen leivänparannusaine, sen käyttö ja valmistusmenetelmä
US7618950B2 (en) 2004-07-07 2009-11-17 Arigen Pharmaceuticals, Inc. Method for treatment and prevention of herpes zoster by topical application
JP4964473B2 (ja) * 2006-02-10 2012-06-27 アリジェン製薬株式会社 ピリミジンヌクレオシド誘導体及びその塩
US8076302B2 (en) 2007-02-15 2011-12-13 Arigen Pharmaceuticals, Inc. Pyrimidine nucleoside derivatives and salts thereof
US8658618B2 (en) 2009-10-14 2014-02-25 Adherex Technologies, Inc. Methods for preventing or reducing neurotoxicity associated with administering DPD inhibitors in combination with 5-FU and 5-FU prodrugs

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1601020A (en) * 1978-04-24 1981-10-21 Stichting Grega Vzw 2'-deoxy-5 (2-halogenovinyl)-uridines
US4247544A (en) * 1979-07-02 1981-01-27 The Regents Of The University Of California C-5 Substituted uracil nucleosides

Also Published As

Publication number Publication date
US4386076A (en) 1983-05-31
ES8205234A1 (es) 1982-06-01
CA1150247A (en) 1983-07-19
JPS5687599A (en) 1981-07-16
DE3064165D1 (en) 1983-08-18
EP0031128B1 (en) 1983-07-13
EP0031128A1 (en) 1981-07-01
ES498020A0 (es) 1982-06-01

Similar Documents

Publication Publication Date Title
FR2448794B1 (enExample)
FR2448141B1 (enExample)
FR2448606B1 (enExample)
BR8002583A (enExample)
BR8006808A (enExample)
JPS5748160B2 (enExample)
FR2450337B1 (enExample)
FR2447046B3 (enExample)
FR2449923B1 (enExample)
FR2449124B1 (enExample)
FR2448044B1 (enExample)
FR2464072B1 (enExample)
DE2909272C2 (enExample)
FR2447834B2 (enExample)
FR2447433B3 (enExample)
DE2933653C2 (enExample)
FR2448545B2 (enExample)
FR2450268B1 (enExample)
FR2446807B1 (enExample)
AU79826S (enExample)
AU79918S (enExample)
AU79557S (enExample)
AU79950S (enExample)
BR5901094U (enExample)
AU80228S (enExample)

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term